embolism
US /ˈɛmbəˌlɪzəm/
・UK /ˈembəlɪzəm/
A1 初級
n.名詞加閏日 ; 閏 ; 栓塞
影片字幕
這會致命?這些東西都有可能讓你有生命危險 (This Much Will Kill You)
03:41
- The amount of air pressure from this could burst your lungs, or, alternatively, create an embolism that travels to your heart.
185 分貝的聲音所造成的空氣壓力能使你的肺部爆裂,或是會在你的肺靜脈產生栓塞 。
世衛組織稱牛津-阿斯利康Covid疫苗與血栓無關 - BBC News (Oxford-AstraZeneca Covid vaccine not linked to blood clots, WHO says - BBC News)
02:33
- What I've been talking about this to Professor Paul Hunter from the University of East Anglia School of Medicine and asked him what the data shows us about potential harmful side effects from this vaccine in in England and the United Kingdom, we have what's called a yellow card scheme so that whenever you give a drug or or or a vaccine to somebody and they develop an adverse event in the time after that, you generally if you don't know it's for certain that it's not related to the vaccine or the drug, you then fill out a yellow card and these are collated and I've looked at the most recent analyses of both the fighter and the Oxford AstraZeneca vaccines, and both of them have reported the presence of, uh, pulmonary thrombosis embolism, which is sort of blood clots on the lung.
我一直在和東安格利亞大學醫學院的保羅-亨特教授談論這個問題,並問他數據顯示我們關於這種疫苗的潛在有害副作用在英格蘭和英國,我們有所謂的黃牌計劃,所以每當你給某人一種藥物或或或疫苗,他們在之後的時間裡發展不良事件。一般來說,如果你不知道它是肯定的,它是不相關的疫苗或藥物,你就會填寫一張黃卡,這些都是經過整理的,我看了最近的分析,鬥士和牛津阿斯利康疫苗,他們都報告了存在,呃,肺血栓栓塞,這是一種肺部的血塊。
- So I think we can be pretty sure that neither visor nor us Oxford AstraZeneca actually increased the risk of anybody getting from the embolism.
是以,我認為我們可以非常肯定,無論是遮陽板還是我們牛津阿斯利康實際上增加了任何人從栓塞中獲得的風險。
阿斯利康發現疫苗不會增加血栓風險 (AstraZeneca finds no increased blood clot risk from vaccine)
01:22
- In a statement, the company said AstraZeneca has shown no evidence of an increased risk of pulmonary embolism, deep vein thrombosis or thrombosis subpoena in any defined age group, gender batch or in any particular country, the drugmaker added 37 blood related incidents have been reported so far, which it says is similar across other licensed covid 19 vaccines.
在一份聲明中,該公司表示,阿斯利康沒有顯示出任何證據表明在任何確定的年齡組,性別批次或在任何特定的國家,肺栓塞,深靜脈血栓或血栓傳票的風險增加,該製藥商補充說,到目前為止,已經有37起血液相關事件的報告,它說,在其他許可的covid 19疫苗中,這是類似的。